Topical Steroid Complications — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Hypothalamic-pituitary-adrenal (HPA) axis suppression from systemic absorption
The best answer is “Hypothalamic-pituitary-adrenal (HPA) axis suppression from systemic absorption”. NICE recommends treatment matched to severity, high-impact sites, functional burden, comorbidity and prior response; narrowband UVB is a finite specialist option for plaque or guttate psoriasis that topical therapy cannot control. The alternatives “Telangiectasia, after clinicopathological correlation, after specialist assessment”, “Skin atrophy, after specialist assessment”, “Contact dermatitis to the steroid”, “Folliculitis, within an appropriate UK pathway” are clinically adjacent possibilities, but they do not fit the defining morphology, distribution, histopathology, risk signal or management sequence in this stem.
Reference: NICE CG153 psoriasis recommendations: https://www.nice.org.uk/guidance/cg153/chapter/Recommendations